FI933512A - 2-substituerade kinolinylmetoxifenylaettiksyraderivat - Google Patents

2-substituerade kinolinylmetoxifenylaettiksyraderivat Download PDF

Info

Publication number
FI933512A
FI933512A FI933512A FI933512A FI933512A FI 933512 A FI933512 A FI 933512A FI 933512 A FI933512 A FI 933512A FI 933512 A FI933512 A FI 933512A FI 933512 A FI933512 A FI 933512A
Authority
FI
Finland
Prior art keywords
carbon atoms
chain
straight
hydroxyl
phenyl
Prior art date
Application number
FI933512A
Other languages
English (en)
Other versions
FI933512A0 (fi
Inventor
Michael Matzke
Klaus-Helmut Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Reiner Mueller-Peddinhaus
Armin Hatzelmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI933512A0 publication Critical patent/FI933512A0/fi
Publication of FI933512A publication Critical patent/FI933512A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
FI933512A 1992-08-11 1993-08-09 2-substituerade kinolinylmetoxifenylaettiksyraderivat FI933512A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226519A DE4226519A1 (de) 1992-08-11 1992-08-11 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate

Publications (2)

Publication Number Publication Date
FI933512A0 FI933512A0 (fi) 1993-08-09
FI933512A true FI933512A (fi) 1994-02-12

Family

ID=6465285

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933512A FI933512A (fi) 1992-08-11 1993-08-09 2-substituerade kinolinylmetoxifenylaettiksyraderivat

Country Status (22)

Country Link
US (1) US5597833A (fi)
EP (1) EP0582908B1 (fi)
JP (1) JPH06157463A (fi)
KR (1) KR940003936A (fi)
CN (1) CN1087337A (fi)
AT (1) ATE166645T1 (fi)
AU (1) AU668574B2 (fi)
CA (1) CA2103521A1 (fi)
CZ (1) CZ151193A3 (fi)
DE (2) DE4226519A1 (fi)
DK (1) DK0582908T3 (fi)
ES (1) ES2117070T3 (fi)
FI (1) FI933512A (fi)
HU (1) HUT70041A (fi)
IL (1) IL106622A (fi)
MX (1) MX9304582A (fi)
MY (1) MY108877A (fi)
NO (1) NO179513C (fi)
NZ (1) NZ248343A (fi)
PL (1) PL300026A1 (fi)
SK (1) SK86593A3 (fi)
ZA (1) ZA935795B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
US6069151A (en) * 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
GB2356139A (en) * 1999-11-15 2001-05-16 Bayer Ag Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
TW200740435A (en) * 2005-08-10 2007-11-01 Takeda Pharmaceuticals Co Therapeutic agent for diabetes
JP2010511632A (ja) 2006-11-30 2010-04-15 アミラ ファーマシューティカルス，インコーポレーテッド ５−リポキシゲナーゼ活性化タンパク質インヒビターおよび一酸化窒素モジュレーターを含んでいる組成物および治療法
WO2015120038A1 (en) 2014-02-04 2015-08-13 Bioscience Pharma Partners, Llc Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH0742488Y2 (ja) * 1989-05-23 1995-10-04 川崎重工業株式会社 移動床型脱じん・反応装置
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
NO932709D0 (no) 1993-07-27
EP0582908A1 (de) 1994-02-16
DE59308603D1 (de) 1998-07-02
KR940003936A (ko) 1994-03-14
CN1087337A (zh) 1994-06-01
DE4226519A1 (de) 1994-02-17
SK86593A3 (en) 1994-06-08
JPH06157463A (ja) 1994-06-03
CZ151193A3 (en) 1994-03-16
ZA935795B (en) 1994-03-07
HU9302313D0 (en) 1993-10-28
AU668574B2 (en) 1996-05-09
ES2117070T3 (es) 1998-08-01
PL300026A1 (en) 1994-03-21
MX9304582A (es) 1994-02-28
NO932709L (no) 1994-02-14
DK0582908T3 (da) 1999-01-18
CA2103521A1 (en) 1994-02-12
MY108877A (en) 1996-11-30
NZ248343A (en) 1995-03-28
EP0582908B1 (de) 1998-05-27
FI933512A0 (fi) 1993-08-09
AU4425393A (en) 1994-02-17
IL106622A (en) 1997-02-18
NO179513C (no) 1996-10-23
HUT70041A (en) 1995-09-28
US5597833A (en) 1997-01-28
IL106622A0 (en) 1993-12-08
ATE166645T1 (de) 1998-06-15
NO179513B (no) 1996-07-15

Similar Documents

Publication Publication Date Title
ES2625636T3 (es) Proceso para preparar inhibidores del metabolismo de nucleósidos
ES506237A0 (es) Procedimiento para la obtencion de derivados n-sustituidos de la 1-desoxijirimicina
FI933512A (fi) 2-substituerade kinolinylmetoxifenylaettiksyraderivat
ES2158876T3 (es) Derivado de galantamina, un procedimiento para su preparacion y su utilizacion como medicamento.
HUP9801725A1 (hu) Új benzimidazol-, benzoxazol- és benzotiazolszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
AU7748587A (en) Phenolic benzothiazole derivatives and their use as corrosion inhibitors
AU581324B2 (en) Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
ES8306137A1 (es) "procedimiento para la preparacion de nuevas amidas de acidos carboxilicos".
SE8802412D0 (sv) Thiourea derivatives
AU2005216200A1 (en) Maleiimide anti-tumor phosphatase inhibitors
ATE14724T1 (de) Alphacarbamoyl-pyrrolpropionitrile, verfahren zu ihrer herstellung, sowie pharmazeutische praeparate die diese verbindungen enthalten.
Zhang et al. Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers
ES497467A0 (es) Un procedimiento para la preparacion de derivados de imadazol n- sustituidos, o su sales de adicion de acido.
ES8506009A1 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
JPS5470830A (en) Color photographic material
FR2398061A1 (fr) Nouveau procede de preparation de sels organiques mixtes de l'aluminium
FR2450106A1 (fr) Compositions pharmaceutiques ou veterinaires renfermant une quantite physiologiquement active d'une phenylethylamine, a activite de stimulation sexuelle

Legal Events

Date Code Title Description
FD Application lapsed